DocGo Q1 2024 GAAP EPS $0.10 Beats $0.08 Estimate, Sales $192.10M Beat $187.93M Estimate
Portfolio Pulse from Benzinga Newsdesk
DocGo (NASDAQ:DCGO) reported Q1 2024 earnings of $0.10 per share, surpassing the consensus estimate of $0.08. Sales reached $192.10M, exceeding estimates of $187.93M and marking a 70% increase from the previous year.
May 08, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DocGo reported a strong Q1 2024 with earnings and sales surpassing estimates, indicating robust growth.
DocGo's earnings and sales beat not only demonstrates the company's ability to outperform market expectations but also indicates a significant year-over-year growth of 70% in sales. This strong performance is likely to positively influence investor sentiment and could lead to an uptick in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100